LN18 glioma cells were kept as controls or treated with 80 μM DAPT for 0.5 h, 1 h, 4 h, 8 h, or 24 h and then Smad1/5 phosphorylation were examined. This evidence concerns the gene SMAD1 and central nervous system cancer.